BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as a ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

BioNexus Gene Lab Corporation, a Nasdaq-listed company, has unveiled an Ethereum-focused treasury strategy, emphasizing ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

BioNexus Gene Lab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports ...

The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...